Skip to main content
Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS
Download the PDF

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Case Study

Acute Pain Study

CNS
Download the PDF

603

Enrolled Participants

99%

Retention

90%

Medication Adherence

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS
Download the PDF

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Case Study

Acute Pain Study

CNS
Download the PDF

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Case Study

Acute Pain Study

CNS
Download the PDF

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

Download the PDF
CNS

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Back to Top
Case Study

Acute Pain Study

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

CNS
Download the PDF

Challenge

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

‍

Solution

  • Easy-to-use NRS pain scales were given to patients via the ObvioHealth app—multiple times on the first day, then once per day for 5 days.
  • Clinicians entered the data into the app for in-patient participants. Post surgery, these patients reported their health status daily from home via the app, as did out-patients, to quickly detect AEs.
  • ObvioHealth enlisted 15 sites across 4 APAC countries: Singapore, Thailand, Malaysia, and the Philippines.

‍

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

CNS

Sub-Clinical Mood Disorders

A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.

› Read More
CNS

ADHD Study

A biopharmaceutical company is seeking a Phase IV clinical trial to confirm the safety and efficacy of its ADHD therapeutic on a more real-world population. Phases I-III included narrow inclusion and exclusion criteria.

› Read More